Human myasthenic sera reduce acetylcholine sensitivity of human muscle cells in tissue culture.
D000109:Acetylcholine / Q000494:pharmacology*; D000200:Action Potentials / Q000187:drug effects; D000937:Antigen-Antibody Reactions; D002038:Bungarotoxins / Q000378:metabolism; D003165:Complement System Proteins / Q000378:metabolism; D006801:Humans; D007106:Immune Sera / Q000494:pharmacology*; D007074:Immunoglobulin G; D007700:Kinetics; D008564:Membrane Potentials / Q000187:drug effects; D009132:Muscles / Q000276:immunology*; D009157:Myasthenia Gravis / Q000276:immunology*; D011950:Receptors, Cholinergic / Q000187:drug effects* / Q000378:metabolism; D013696:Temperature
D002038:Bungarotoxins; D007106:Immune Sera; D007074:Immunoglobulin G; D011950:Receptors, Cholinergic; D003165:Complement System Proteins; D000109:Acetylcholine